Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...

ACM impedes the heart from pumping blood to the rest of the body, and is a leading cause of sudden cardiac death in young ...

Researchers found a "garbage man" enzyme that tags toxic clumps of proteins in the brain for removal, and saw a correlation ...

A team of researchers has seemingly managed to do just that: they successfully converted a Type A human kidney into a ...

After losing a kidney to cancer at 3, Stevie Elam persevered to become a Division I basketball freshman with pro potential at UW-Milwaukee.

Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible ...

The disease leads to the progressive growth of fluid-filled cysts in the kidneys, often resulting in kidney failure and other ...

Data from Boehringer Ingelheim’s Phase II apecotrep study was published in The Lancet and presented at the 2025 ASN’s Kidney Week ...

Adults with kidney cancer who received faecal microbiota transplants on top of their existing drugs did better than those who ...

For the first time, clumps of human cells called organoids were fully integrated with the brains of rats—and influenced their behavior.

Fecal microbiota transplants (FMT), can dramatically improve cancer treatment, suggest two groundbreaking studies published ...

A centuries-old medicinal root is gaining renewed scientific attention for its ability to target multiple biological processes involved in hair loss. Androgenetic alopecia (AGA) is the most common ...